NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
30/01/2024
Voltar para busca
Dado oficial do USPTO
NEELYX
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
24
Atualização mais recente
30/01/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42, 44
Data de depósito
15/04/2022
Data de registro
30/01/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/01/2024
Última transação
30/01/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
15/01/2021
Primeiro uso no comércio
01/02/2021
Código do desenho
4
Tipo de titular
03
Localização do titular
Wood Dale, IL, US
Examinador
PARKER, JUSTINE D
Unidade examinadora
L10
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Neelyx Labs Inc
Representantes
Neelyx Labs Inc
Classificação técnica
Classes Nice
Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Basic and clinical research in the field of respiratory science and medicine; Biochemical research; Biochemical research and analysis; Biochemical research and development; Biomedical research services; Computer diagnostic services; Consultancy pertaining to pharmacology; Consulting services in the field of biotechnology; Consulting services in the field of pharmaceutical research and development; Designengineeringresearchdevelopment and testing services in the field of polymeric materialspolymer synthesismaterials customization for medicalscientifictechnological applications; Development of new technology for others in the field of molecular testing and molecular diagnostics; Medical testing for diagnostic purposes featuring laboratory clinical and molecular testing in the field of epidemiology; Diagnostic services in the field of medical instruments for intake and processing reports for laboratory clinical and molecular testing; Diagnostic services in the field of medical instruments for researchdevelopment and clinical testing; DNA analysis services for scientific research purposes; DNA screening for scientific research purposes; Engineering servicesengineering in the field of molecular diagnostics; Genetic testing for scientific research purposes; Genome amplification; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of molecular diagnostics; Medical and scientific researchconducting clinical trials for others; Medical laboratory services; Medical research; Medical research in the field of epidemiology; Medical research services; Pharmaceutical research services; Product research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products for others; Research on the subject of pharmaceuticals; Scientific investigations for medical purposes; Scientific laboratory services; Scientific research; Scientific research consulting; Scientific research in the field of genetics and genetic engineering; Scientific study and research in the field(s) of molecular testing and molecular diagnostics; Structural and functional analysis of genomes
Classe 44
Antibody testing for medical diagnostic or treatment purposes; Consulting services in the fields of diagnostic medical testing and nutrition; Genetic testing of animals for diagnostic or treatment purposes; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical diagnostic testingmonitoring and reporting services; Medical testing for diagnostic or treatment purposes; Medical testing of urinebloodhair follicles and breath; Medical testing services relating to the diagnosis and treatment of disease; Providing information relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals; Testing for medical diagnostic or treatment purposes in the field of infectious diseases; Veterinary specialty services providing advanced medicaldiagnostic or surgical services for animals; Virus testing for medical diagnostic or treatment purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
24 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
30/01/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/11/2023
PUBO
PUBLISHED FOR OPPOSITION
14/11/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/10/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/10/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
06/10/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/10/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
06/10/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/10/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/08/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/08/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
31/08/2023
ALIE
ASSIGNED TO LIE
31/08/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
18/04/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
18/04/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
18/04/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
18/04/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/02/2023
GNRT
NON-FINAL ACTION E-MAILED
02/02/2023
CNRT
NON-FINAL ACTION WRITTEN
02/02/2023
DOCK
ASSIGNED TO EXAMINER
02/02/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
20/04/2022
NWAP
NEW APPLICATION ENTERED
19/04/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NEELYX ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.